GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight
Circulation Research · 2026
DOI: 10.1161/circresaha.126.327683 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation Research, 2026. Verfasst von Tapan A Patel und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Integrative Physiology (T.A.P., J.R., P.K., J.S., K.P.P., M.A.), University of Nebraska Medical Center, Omaha. Hauptthemen laut MEDLINE: Glucagon-Like Peptide-1 Receptor Agonists, Hypertension, Incretins, Cardiovascular Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
GLP-1R (glucagon-like peptide-1 receptor) agonists are transforming therapeutic strategies in hypertension and cardiometabolic syndrome by shifting the focus from merely controlling individual risk factors to modifying the vascular-metabolic biology that underpins these conditions. In addition to promoting weight loss and improved glycemic control, growing clinical and experimental evidence indicates their beneficial effects on endothelial dysfunction, vascular inflammation, leukocyte recruitment, atherosclerotic plaque composition, and cardiorenal pathways involved in sodium regulation and neurohumoral balance, key processes in cardiometabolic-related hypertension and associated heart failure. This review integrates rapid clinical advancements in GLP-1R agonists with emerging mechanistic insights, clarifying which findings are well-established and which remain inferential, and identifying significant translational gaps that would provide deeper insight into cardiometabolic diseases. Key priorities include determining which benefits reflect direct GLP-1R signaling within cardiovascular/renal tissues versus secondary cardiometabolic changes, establishing cell type–resolved GLP-1R localization in human heart and kidney, and developing response biomarkers for cardiovascular and heart failure outcomes. Addressing these issues through detailed trial phenotyping, advanced mechanistic imaging, and relevant experimental models will facilitate personalized application of existing therapies and inform the development of next-generation incretin-based strategies aimed at durable vascular protection and blood pressure regulation for better cardiovascular health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cellular and Integrative Physiology (T.A.P., J.R., P.K., J.S., K.P.P., M.A.), University of Nebraska Medical Center, Omaha.
- Division of Clinical Pharmacology, Department of Pharmacology (K.K.), Jichi Medical University, Japan.
- Division of Cardiovascular Medicine, Department of Internal Medicine (K.K.), Jichi Medical University, Japan.
- Division of Integrative Physiology, Center for Integrative Physiology, Kansai Electric Power Medical Research Institute, Kyoto, Japan (T.Y.).
- Department of Diabetes, Endocrinology and Metabolism/Rheumatology and Clinical Immunology, Gifu University Graduate School of Medicine, Japan (T.Y.).
- Center for One Medicine Innovative Translational Research, Gifu University Institute for Advanced Study, Japan (T.Y.).
ORCID-Profile: Tapan A Patel, Jill Rose, Kenichi Katsurada, Toshihiko Yada, Jeffrey Salomon, Kaushik P Patel, Mabruka Alfaidi
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Patel, T. A., Rose, J., Katsurada, K., Yada, T., Koutakis, P., Salomon, J., Patel, K. P., & Alfaidi, M. (2026). GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight. Circulation Research. https://doi.org/10.1161/circresaha.126.327683
Vancouver
Patel TA, Rose J, Katsurada K, Yada T, Koutakis P, Salomon J, et al. GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight. Circulation Research. 2026. doi:10.1161/circresaha.126.327683
BibTeX
@article{Patel2026,
author = {Patel, Tapan A and Rose, Jill and Katsurada, Kenichi and Yada, Toshihiko and Koutakis, Panagiotis and Salomon, Jeffrey and Patel, Kaushik P and Alfaidi, Mabruka},
title = {GLP-1 Receptor Agonists: From Clinical Success to Mechanistic Insight},
journal = {Circulation Research},
year = {2026},
doi = {10.1161/circresaha.126.327683}
}
EUVIMED